Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720902 · ClinicalTrials.gov registry record · Phase 4
Adult Growth Hormone Deficiency and Cardiovascular Risk
A Phase 4 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT00720902: Clinical Trial Phase 4 study, sponsored by Columbia University.
NCT00720902 is a Phase 4 study that was terminated before completion, run by Columbia University. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00720902, a Phase 4 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This protocol will assess the cardiovascular risk associated with growth hormone deficiency in adults. We will use multiple modalities to assess risk for heart attacks or strokes including blood work, ultrasound, MRI and endothelial cell biopsies in both patients who are growth hormone deficient and in patients with normal growth hormone secretion. We hypothesize that adults with growth hormone deficiency will have results suggestive of an increased risk for cardiovascular disease.
Primary Outcome
C-reactive protein (CRP) levels in GH sufficient and GH deficient participants
Interventions
- PROCEDURE MRI
- PROCEDURE Blood draws
- PROCEDURE Carotid ultrasound
- DRUG growth hormone releasing hormone (GHRH) & arginine
- PROCEDURE Endothelial cell biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-02 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Why NCT00720902 stopped before completion
NCT00720902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which MRI is the first listed.
NCT00720902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00720902 about?
NCT00720902 is a clinical study titled "Adult Growth Hormone Deficiency and Cardiovascular Risk". This protocol will assess the cardiovascular risk associated with growth hormone deficiency in adults. We will use multiple modalities to assess risk for heart attacks or strokes including blood work, ultrasound, MRI and endothelial cell biopsies in both patients who are growth hormone deficient and...
What is the current status of trial NCT00720902?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2007-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00720902?
The interventions under investigation include: MRI (PROCEDURE), Blood draws (PROCEDURE), Carotid ultrasound (PROCEDURE), growth hormone releasing hormone (GHRH) & arginine (DRUG), Endothelial cell biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00720902?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00720902's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia